| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $40.0B | $35.9B | $32.7B | $29.3B | $24.1B | $21.8B | $23.0B | $20.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $24.0B | $23.6B | $21.0B | $18.8B | $15.8B | $14.1B | $15.0B | $13.0B |
| Net Income | $20.1B | $19.7B | $17.3B | $15.0B | $12.3B | $10.9B | $12.1B | $10.3B |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $99.6B | $94.5B | $90.5B | $85.5B | $82.9B | $80.9B | $72.6B | $69.2B |
| Current Assets | $37.8B | $34.0B | $33.5B | $30.2B | $27.6B | $27.6B | $21.0B | $18.2B |
| Cash & Equivalents | $17.2B | $12.0B | $16.3B | $15.7B | $16.5B | $16.3B | $7.8B | $8.2B |
| Total Liabilities | $61.7B | $55.4B | $51.8B | $49.9B | $45.3B | $44.7B | $37.9B | $35.2B |
| Current Liabilities | $35.0B | $26.5B | $23.1B | $20.9B | $15.7B | $14.5B | $13.4B | $11.3B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $23.1B | $19.9B | $20.8B | $18.8B | $15.2B | $10.4B | $12.8B | $12.7B |
| Investing Cash Flow | $0.7B | $-1.9B | $-2.0B | $-4.3B | $-0.2B | $1.4B | $-0.6B | $-3.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-19.0B | $-20.6B | $-17.8B | $-12.7B | $-14.4B | $-4.0B | $-12.1B | $-11.2B |